The Latest Breaking News from FDA

Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.

The Prime Minister said the Civil Service was ‘admired across the world’ after a backlash to his comments last week.

UniQure stock doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease treatment.

Red No. 3 was banned from all cosmetic products and topical drugs in 1990

The majority of caregivers of patients with tuberous sclerosis complex (TSC) planned to continue Epidiolex treatment, citing benefits like reduced seizure frequency and improvements in cognition and communication. That's according to data from the BECOME-TSC (BEhavior, COgnition, and More with Epidiolex) caregiver survey, revealed by Jazz Pharmaceuticals plc (NASDAQ: JAZZ).…

The FDA is taking steps to ban red 3, which is derived from oil, amid concerns about its health effects

The head of the FDA union has written to the Prime Minister, describing his remarks as ‘so disappointing’.

Mark McAfee's raw milk products have been recalled over bird flu contamination

The FDA union said the Prime Minister’s language about civil servants in his Plan for Change speech was ‘far more damaging than you had considered’.

Exclusive: FDA general secretary urges PM to rethink ‘Trumpian’ language about Whitehall

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression outcomes in treated patients.